Excel Diagnostics and Nuclear Oncology Center
2 clinical trials · Sponsor
◉ Watch Excel Diagnostics and Nuclear Oncology Center
| Record | Firm | Date |
|---|---|---|
| Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET. (NCT04276597) | Excel Diagnostics and Nuclear Oncology Center | 2020-03-04 |
Track Excel Diagnostics and Nuclear Oncology Center automatically
Every clearance here is in the API, with alerts when new ones post.